Intellia Therapeutics (NASDAQ:NTLA) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Intellia Therapeutics (NTLA) operate in?

Intellia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Intellia Therapeutics Stock (NASDAQ: NTLA) stock price, news, charts, stock research, profile.

Open	$9.48
Close	$9.50
Volume / Avg.	3.33M / 2.89M
Day Range	$9.32 - $9.69
52 Wk Range	9.25 - 34.87
Market Cap	$969.60M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	29
Short Interest	24.23%
Days to Cover	8.78

Recent News

Cathie Wood's Ark Invest Loads Up On Intellia Therapeutics Which Laid Off Over A Quarter Of Its Workforce

Ark Invest, led by Cathie Wood, made significant trades in 5 companies on Friday: RXRX, ILMN, NTLA, NET, and ADPT.

Rounak Jain

Why Is Intellia Therapeutics Stock Trading Lower On Friday?

Intellia Therapeutics prioritizes late-stage gene-editing programs for HAE and ATTR amyloidosis in 2025, announces leadership changes, and prepares for commercialization.

Vandana Singh

2 Gene-Editing Stocks Positioned for a Strong Comeback in 2025

Gene-editing kicked off 2024 with a bang in the medical sector but closed the year with a whimper. It started with the FDA approval for the first CRSPR-based gene therapy treatment for sickle cell anemia (SCA)

MarketBeat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug 24

Sep 24

Oct 24

Nov 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$9.48
Close	$9.50
Volume / Avg.	3.33M / 2.89M
Day Range	$9.32 - $9.69
52 Wk Range	9.25 - 34.87
Market Cap	$969.60M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	29
Short Interest	24.23%
Days to Cover	8.78

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Intellia Therapeutics (NTLA) stock?

You can purchase shares of Intellia Therapeutics (NASDAQ:NTLA) through any online brokerage.

View our list of the best stock brokerages

Who are Intellia Therapeutics (NTLA) competitors?

Other companies in Intellia Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT) and Syndax Pharmaceuticals (NASDAQ:SNDX).

What is the forecast, or price target, for Intellia Therapeutics (NTLA) stock?

Intellia Therapeutics has a consensus price target of $62.58.

What is the current price for Intellia Therapeutics (NTLA)?

The stock price for Intellia Therapeutics (NASDAQ: NTLA) is $9.52 last updated January 17, 2025 at 7:14 PM EST.

Does Intellia Therapeutics (NTLA) pay a dividend?

There are no upcoming dividends for Intellia Therapeutics.

When is Intellia Therapeutics (NASDAQ:NTLA) reporting earnings?

Intellia Therapeutics’s Q4 earnings are confirmed for Thursday, February 20, 2025.

Is Intellia Therapeutics (NTLA) going to split?

There is no upcoming split for Intellia Therapeutics.

What sector and industry does Intellia Therapeutics (NTLA) operate in?

Intellia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Intellia Therapeutics

Intellia Therapeutics (NTLA) Forecast